Atrás
Rango del Día
$10.25
$10.71
Rango de 52 Semanas
$4.85
$14.39
Volumen
1,293,346
Promedio 50D / 200D
$11.16
/
$9.67
Cierre Anterior
$10.76
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -32.0 | 0.3 |
| P/B | 7.5 | 2.9 |
| ROE % | -30.2 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$19.25
+80.9%
Low: $16.00
High: $24.00
EPS Futuro
-$0.45
Ingresos Est.
1.1 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.88
$0.88 – $0.88
|
420 M | 3 |
| FY2029 |
-$0.33
-$0.33 – -$0.33
|
140 M | 3 |
| FY2028 |
-$0.58
-$1.24 – $1.12
|
32 M | 9 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -42.10M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-30.23%
ROIC-20.11%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio19.66
Interest Coverage0.00
Valoración
P/E Ratio
-31.95
P/B Ratio7.46
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -42.76M |
| ROE | -30.23% | ROA | -22.10% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -42.10M |
| ROIC | -20.11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 19.66 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -31.95 | P/B Ratio | 7.46 |
| P/S Ratio | N/A | PEG Ratio | 1.11 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.37B | Enterprise Value | 1.35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -42.76M | -47.91M | -29.07M | -29.15M | -33.94M |
| EPS (Diluted) | -0.29 | -0.47 | -0.29 | -0.45 | -1.49 |
| Gross Profit | -132,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -49.33M | -51.52M | -33.92M | -29.91M | -32.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 193.44M | 110.90M | 89.40M | 123.02M | 38.48M |
| Total Liabilities | 10.20M | 11.26M | 6.86M | 15.56M | 21.40M |
| Shareholders' Equity | 183.24M | 99.64M | 82.55M | 107.46M | 17.08M |
| Total Debt | 753,000.0 | 1.03M | 1.34M | 9.18M | 14.63M |
| Cash & Equivalents | 18.91M | 34.10M | 32.40M | 12.59M | 36.83M |
| Current Assets | 191.66M | 109.43M | 87.55M | 122.62M | 37.96M |
| Current Liabilities | 9.75M | 10.51M | 5.82M | 13.40M | 12.72M |